Reuters) - Coronado Biosciences Inc said its treatment for Crohn's disease, a type of inflammatory bowel disease, failed the main goal of improving patients' response to the disease in a mid-stage study, sending its shares down 70 percent.
The treatment, Trichuris suis ova, comprised eggs taken...